Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Administrator Seema Verma: What Industry Can Expect

Executive Summary

The Senate confirmed former health-policy consultant Seema Verma as administrator of the US Centers for Medicare and Medicaid Services earlier this month, and she was sworn in March 14. Medtech Insight took a look at some of Verma's policy positions affecting industry, including potential changes to accountable care organizations, appropriate-use criteria, the Centers for Medicare and Medicaid Innovation, lab payments, and telehealth services.

You may also be interested in...



CMS Proposes High Payment Score For Use Of Imaging Appropriate-Use Criteria

In a proposed rule, the US Medicare agency said clinicians may count use of advanced imaging appropriate use criteria (AUC) through clinical decision support as a new and highly-weighted portion of an overall score to win reimbursement through the Merit-Based Incentive Payment System. The move was touted by the imaging industry.

Market Intel: Unravelling Bundled Payments: A New Chapter In Reimbursement For Orthopedics

The shift in health care reimbursement from a fee-for-service model to one which is based on value and an emphasis on accountability for care quality and health care costs is here to stay. In orthopedics, as in other therapy sectors, physicians are having to grapple with new alternative payment models and meeting the requirements that come with these new reimbursement methods. Strategies for adopting these value-based systems, including challenges and trends, and what it all means for surgeons, dominated much of the discussion at this year's American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Diego.

Labs Have Two More Months To Report Private-Payer Data, CMS Says

The US Medicare agency will allow laboratories two additional months – until May 30, 2017 – to report their private-payer pricing data, which will serve as the basis for clinical laboratory Medicare reimbursements starting in January. The agency said it is responding to industry feedback that more time is needed to collect the data.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel